Tempus AI Earnings Turn Clinical Data Into a Margin Flywheel—But GAAP Profit Is Still the Test
Tempus AI’s Q3 shows real operating leverage as diagnostics feed a higher-margin data business. GAAP profit, cash conversion and dilution remain the test.
Read the story
